At Zoiko Healthcare, research and innovation are central to our commitment to transform healthcare for the better. Our cross-functional teams operate at the intersection of scientific rigor, technological advancement, and patient need — ensuring every solution we create is built for both medical efficacy and social impact.
Our innovation priorities are aligned with some of the most pressing healthcare burdens globally. Our pipeline reflects deep expertise in the following therapeutic areas:
Early detection, targeted therapies, and biosimilars for solid tumors and hematologic malignancies.
– Advancing treatments for hypertension, heart failure, lipid disorders, and post-MI care.
– Research into next-gen oral antidiabetics, insulin alternatives, and glucose-modulating nutraceuticals.
Non-opioid pharmacological pathways, including NSAIDs, neuropathic agents, and combination therapies.
Inhalables and novel formulations for asthma, COPD, and viral respiratory syndromes.
Advanced delivery systems for chronic inflammatory conditions, pigmentation, and anti-aging solutions.
Our pipeline spans discovery through commercialization with each project evaluated against therapeutic value, clinical feasibility, and public health relevance. We actively develop biosimilars, novel delivery mechanisms, fixed-dose combinations, and reformulations tailored for diverse global markets.
We maintain strategic R&D labs and technology alliances across the USA, UK, India, and Africa. Through joint ventures, CROs, and biotech alliances, we harness external innovation while supporting in-house scientific acceleration. Our Open Innovation Framework welcomes institutional, academic, and early-stage biotech partners.
Innovation at Zoiko extends beyond the molecule. We explore AI-assisted diagnostics, remote monitoring devices, smart inhalers, and medication adherence platforms — shaping a digital-first model for future care delivery.
We conduct multi-phase clinical trials with regional regulatory oversight and global reporting standards. Our clinical operations team publishes extensively in international journals, and we support transparent reporting of all study outcomes.
We welcome partnerships across the value chain — from research and clinical trials to distribution, licensing, and investment. We invite you to connect at:
